Article | September 21, 2022

Writing A Clinical Study Protocol As A Regulatory Document

By Fadwa Dabbah, Ph.D., Medical Writer


A few years ago, when I was a staff member in a clinical research site, I always found the study protocol to be a very dependable reference. When I needed information about the activities to be performed at each visit or how to best classify the intensity of adverse event and protocol deviations, I could always refer to the study protocol. As a medical writer at Bioforum, when I write a clinical study protocol, I have a wider perspective on the general concept of its role as a regulatory document. The study is presented using clear and unambiguous essential rules to facilitate the compliance of all study stakeholders including the Investigator, Sponsor, study coordinator, and monitor within the standards of Good Clinical Practice. Such compliance and consistency are the pillars by which new drug / biologic or medical device approvals are supported.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader

Bioforum the Data Masters Inc.